LSBCF (LakeShore Biopharma Co) Long-Term Debt: $3.24 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Long-Term Debt?

LakeShore Biopharma Co LSBCF Long-Term Debt is $3.24 Mil as of Mar. 2025.

LakeShore Biopharma Co's Long-Term Debt for the quarter that ended in Mar. 2025 was $3.24 Mil.

LakeShore Biopharma Co's quarterly Long-Term Debt declined from Mar. 2024 ($13.75 Mil) to Sep. 2024 ($11.11 Mil) and declined from Sep. 2024 ($11.11 Mil) to Mar. 2025 ($3.24 Mil).

LakeShore Biopharma Co's annual Long-Term Debt declined from Mar. 2023 ($42.64 Mil) to Mar. 2024 ($13.75 Mil) and declined from Mar. 2024 ($13.75 Mil) to Mar. 2025 ($3.24 Mil).

LakeShore Biopharma Co  (OTCPK:LSBCF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

LakeShore Biopharma Co Long-Term Debt Related Terms

LakeShore Biopharma Co Long-Term Debt Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Long-Term Debt Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Long-Term Debt
0.17 40.02 42.64 13.75 3.24

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only 42.64 49.60 13.75 11.11 3.24
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $3.24 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Long-Term Debt of $3.24 Mil as of Mar. 2025.
Is LakeShore Biopharma Co's Long-Term Debt too high?
LakeShore Biopharma Co's current Long-Term Debt is $3.24 Mil.
How does LakeShore Biopharma Co's Long-Term Debt compare to ACUT and PPCB?
LakeShore Biopharma Co's Long-Term Debt of $3.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. LakeShore Biopharma Co's current Long-Term Debt is $3.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Long-Term Debt of $3.24 Mil. The current Long-Term Debt is $3.24 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Long-Term Debt is $3.24 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.